Lin Cong

Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing)

SCHOLARLY PAPERS

1

DOWNLOADS

43

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

The Efficacy and Plasma ctDNA as a Biomarker of Dual PD-1 and HER2 Blockade in HER2-Positive Gastric or Gastroesophageal Junction Cancers

Number of pages: 25 Posted: 10 Aug 2022
Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), 3D Medicines, Inc. - Medical Affairs, Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), 3D Medicines, Inc. - Medical Affairs, 3D Medicines, Inc. - Medical Affairs, 3D Medicines, Inc. - Medical Affairs, 3D Medicines, Inc. - Medical Affairs, Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) and Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing)
Downloads 43 (914,165)

Abstract:

Loading...

circulating tumor DNA, HER2 amplification, gastric or gastroesophageal junction cancers, trastuzumab, anti-PD-1 immunotherapy